StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research report sent to investors on Saturday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Global Cord Blood stock opened at $1.75 on Friday. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50. The company has a market capitalization of $212.71 million, a P/E ratio of 2.73 and a beta of 0.16. The stock’s 50 day moving average is $1.27 and its 200 day moving average is $1.36.
About Global Cord Blood
Featured Stories
- Five stocks we like better than Global Cord Blood
- Low PE Growth Stocks: Unlocking Investment Opportunities
- How to Invest in Silver: A Beginner’s Guide
- About the Markup Calculator
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- Insider Buying Explained: What Investors Need to Know
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.